Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease

Autor: Salvatore Nigro* a, Cécile Bordier* b, i, Antonio Cerasa c, Rita Nisticò c, Giuseppe Olivadese c, Basilio Vescio d, Maria Giovanna Bianco e, Antonino Fiorillo e, Gaetano Barbagallo f, Marianna Crasà c, Andrea Quattrone f, Maurizio Morelli f, Gennarina Arabia f, Antonio Augimeri d, Carlo Nicolini b, Angelo Bifone b, g, Aldo Quattrone c, h

Publikováno v: Parkinsonism & related disorders 67 (2019): 14–20. doi:10.1016/j.parkreldis.2019.09.006
info:cnr-pdr/source/autori:Salvatore Nigro* a, Cécile Bordier* b,i, Antonio Cerasa c, Rita Nisticò c, Giuseppe Olivadese c, Basilio Vescio d, Maria Giovanna Bianco e, Antonino Fiorillo e, Gaetano Barbagallo f, Marianna Crasà c, Andrea Quattrone f, Maurizio Morelli f, Gennarina Arabia f, Antonio Augimeri d, Carlo Nicolini b, Angelo Bifone b,g, Aldo Quattrone c,h/titolo:Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease/doi:10.1016%2Fj.parkreldis.2019.09.006/rivista:Parkinsonism & related disorders/anno:2019/pagina_da:14/pagina_a:20/intervallo_pagine:14–20/volume:67

Introduction Apomorphine is a dopamine agonist used in Parkinson's disease (PD), which matches levodopa in terms of the magnitude of effect on the cardinal motor features, such as tremor and bradykinesia. The beneficial effect of this treatment on PD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::355bdfeb463becf62660a5b68fbb7ab6
https://doi.org/10.1016/j.parkreldis.2019.09.006